Product
Cidapenem
1 clinical trial
1 indication
Indication
T-Cell LymphomaClinical trial
A Multicenter, Single-arm, Open Clinical Efficacy Observational Study of Cidapenem Combined With Azacitidine and Mitoxantrone Liposome (CAM) Regimen for Relapsed/Refractory Intra-nodal Follicular Adjuvant T-cell Lymphoma (nTFHL)Status: Not yet recruiting, Estimated PCD: 2023-12-01